E-cigarettes in people with substance use disorder

IF 25.4 1区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Lancet Public Health Pub Date : 2025-06-30 DOI:10.1016/s2468-2667(25)00147-1

Joanna M Streck, Nancy A Rigotti

引用次数: 0

Abstract

People with substance use disorder (SUD) have a high prevalence of cigarette smoking.¹ Clinical trials of smoking cessation interventions with efficacy in the overall population of people who smoke have had little success in people with SUD, in part due to methodological limitations.² Innovative and effective tobacco cessation treatments are urgently needed for this group. Nicotine-containing electronic cigarettes (e-cigarettes) are non-combustible nicotine products with substantial evidence of smoking cessation efficacy among people who smoke cigarettes,³ but few randomised trials have tested e-cigarettes for people with SUD.⁴

查看原文本刊更多论文

物质使用障碍患者的电子烟

物质使用障碍（SUD）患者吸烟的患病率很高由于方法学上的限制，戒烟干预在整个吸烟人群中的临床试验收效甚微这一群体迫切需要创新和有效的戒烟治疗。含尼古丁的电子烟（电子烟）是一种不可燃的尼古丁产品，有大量证据表明吸烟的人有戒烟效果，但很少有随机试验测试电子烟对sudd患者的影响

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Public Health Medicine-Public Health, Environmental and Occupational Health

CiteScore

55.60

自引率

0.80%

发文量

305

审稿时长

8 weeks

期刊介绍： The Lancet Public Health is committed to tackling the most pressing issues across all aspects of public health. We have a strong commitment to using science to improve health equity and social justice. In line with the values and vision of The Lancet, we take a broad and inclusive approach to public health and are interested in interdisciplinary research. We publish a range of content types that can advance public health policies and outcomes. These include Articles, Review, Comment, and Correspondence. Learn more about the types of papers we publish.